View Older Stories View More Recent Stories

Apr 10, 2025 05:32AM Bernstein Recommends Three US Biotech Stocks Amid 'Heightened Regulatory Uncertainty'
Apr 2, 2025 09:06AM BioMarin Pharma (BMRN) Announces Positive Pivotal Data for PALYNZIQ in Adolescents with Phenylketonuria
Mar 20, 2025 03:57PM Citi Reiterates Neutral Rating on BioMarin Pharmaceutical Inc. (BMRN)
Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
Mar 15, 2025 04:00AM How could tariffs shake up the pharma sector?
Feb 24, 2025 04:05PM BioMarin Pharma (BMRN) Appoints Timothy P. Walbert to its Board
Feb 24, 2025 07:14AM Oppenheimer Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Outperform
Feb 20, 2025 09:05AM Cantor Fitzgerald Reiterates Overweight Rating on BioMarin Pharmaceutical Inc. (BMRN)
Feb 20, 2025 07:58AM BMO Reiterates Outperform on BioMarin Pharmaceutical Inc. (BMRN) as 'Voxzogo Growth Continues'
Feb 20, 2025 07:44AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $126 at Piper Sandler; 'Strong Execution All Around'
Feb 20, 2025 07:34AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $80 at Scotiabank
Feb 20, 2025 06:46AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $91 at Stifel
Feb 19, 2025 04:35PM After-hours movers: Carvana, Klaviyo, NerdWallet, BioMarin Pharma, and more
Feb 19, 2025 04:06PM BioMarin Pharma (BMRN) Tops Q4 EPS by 37c ; Offers Guidance
Jan 14, 2025 04:59AM Goldman Sachs Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
Jan 13, 2025 12:00PM BioMarin Pharma (BMRN) Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court
Dec 20, 2024 12:46PM BMO Capital Highlights Favorite Names for 2025 in Biotech
Dec 5, 2024 03:15PM BioMarin Pharma (BMRN) 6K contracts of January 6K puts trade at 60c and 65c
Nov 30, 2024 04:00AM Is Trump 2.0 good or bad for healthcare stocks?
Oct 30, 2024 07:18AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $65 at Baird
Oct 30, 2024 07:01AM William Blair Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Market Perform
Oct 30, 2024 06:53AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $84 at Canaccord Genuity
Oct 30, 2024 06:26AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $105 at Leerink Partners
Oct 30, 2024 05:48AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $81 at Citi
Oct 29, 2024 04:05PM BioMarin Pharma (BMRN) Tops Q3 EPS by 38c; raises guidance
Oct 10, 2024 08:20AM Raymond James Resumes BioMarin Pharmaceutical Inc. (BMRN) at Outperform
Oct 4, 2024 07:52AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $86 at Barclays
Oct 4, 2024 04:57AM Increasing unusual put option volume: EVGO LEVI ASHR EQT BMRN FUTU
Sep 25, 2024 05:38AM Goldman Sachs Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
Sep 18, 2024 04:10PM Citi Reiterates Neutral Rating on BioMarin Pharmaceutical Inc. (BMRN)
Sep 17, 2024 08:17AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $78 at Scotiabank
Sep 17, 2024 07:05AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $90 at Truist Securities
Sep 17, 2024 06:19AM Baird Reiterates Neutral Rating on BioMarin Pharmaceutical Inc. (BMRN)
Sep 17, 2024 06:16AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $85 at RBC Capital
Sep 17, 2024 05:24AM BMO Capital Reiterates BioMarin (BMRN) at Outperform: unique opportunity to buy the dip and can attract M&A interest
Sep 16, 2024 03:08PM Barclays Reiterates Overweight Rating on BioMarin Pharmaceutical Inc. (BMRN)
Sep 16, 2024 08:38AM BioMarin Pharma (BMRN) Weakness Tied to Data From Ascendis Pharma (ASND)
Sep 13, 2024 06:40AM Canaccord Genuity Reiterates Hold Rating on BioMarin Pharmaceutical Inc. (BMRN)
Sep 9, 2024 10:34AM Increasing unusual call option volume: SMMT TERN SATS BNTX BRZE FRPT FLUT APLD TECS BMRN
Sep 6, 2024 08:19AM BMO Capital Reiterates Outperform Rating on BioMarin Pharmaceutical Inc. (BMRN)
Sep 5, 2024 08:59AM TD Cowen Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
Sep 5, 2024 08:25AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $122 at Piper Sandler
Sep 5, 2024 07:25AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $95 at Scotiabank
Sep 5, 2024 06:24AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $118 at Truist Securities
Sep 4, 2024 01:00PM BioMarin Pharma (BMRN) Provides New Corporate Strategy, Introduces 2027 Financial Guidance
Sep 4, 2024 12:57PM BioMarin Pharma (BMRN) Enters $600M Revolving Credit Facility
Sep 4, 2024 10:37AM BioMarin Pharma (BMRN) Halted, News Pending
Aug 28, 2024 05:06PM BioMarin Pharma (BMRN) to reduce its global workforce by approximately 225 employees
Aug 28, 2024 06:09AM Bernstein SocGen Group Reiterates Outperform Rating on BioMarin Pharmaceutical Inc. (BMRN)
Aug 28, 2024 05:20AM Goldman Sachs Shares 2 Idiosyncratic Trade Ideas off NVIDIA (NVDA) Earnings, Buy Calls on Dollar General (DG) and BioMarin Pharma (BMRN)
View More Recent Stories View Older Stories